These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26955824)

  • 1. Thrombin Generation Assay and Its Application in the Clinical Laboratory.
    Tripodi A
    Clin Chem; 2016 May; 62(5):699-707. PubMed ID: 26955824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is there a place for thrombin generation assay in routine clinical laboratory?].
    Lecut C; Peters P; Massion PB; Gothot A
    Ann Biol Clin (Paris); 2015; 73(2):137-49. PubMed ID: 25847735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
    Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
    Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
    Morishima Y; Kamisato C
    Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
    Jeong JC; Kim JE; Ryu JW; Joo KW; Kim HK
    Thromb Res; 2013 Nov; 132(5):604-9. PubMed ID: 24060191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin Generation Assays (TGAs).
    Salvagno GL; Berntorp E
    Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombinography: towards a globalization of coagulation tests].
    Péters P; Gothot A
    Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles.
    Gheldof D; Mullier F; Chatelain B; Dogné JM; Chatelain C
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):567-72. PubMed ID: 23807485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
    Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
    Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin Generation Assay Detects Moderate-Intensity Statin-Induced Reduction of Hypercoagulability in Diabetes.
    Park HS; Gu JY; Yoo HJ; Han SE; Park CH; Kim YI; Nam-Goong IS; Kim ES; Kim HK
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1095-1101. PubMed ID: 29669440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin Generation Assay and Hemostatic Profile for Elucidating Hypercoagulability in Endogenous Canine Hyperadrenocorticism.
    Vargas-Mora SE; Romão FG; Dos Santos B; Carvalho MDG; Duarte RCF; De Marco Bernardes V; Lopes PA; Takahira RK
    Top Companion Anim Med; 2021 Nov; 45():100581. PubMed ID: 34509666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.
    Tripodi A; Ammollo CT; Semeraro F; Colucci M; Malchiodi E; Verrua E; Ferrante E; Arnaldi G; Trementino L; Padovan L; Chantarangkul V; Peyvandi F; Mantovani G
    Endocrine; 2017 May; 56(2):298-307. PubMed ID: 27448294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preanalytic processing of rat plasma influences thrombin generation and fibrinolysis assays.
    Brooks MB; Stablein AP; Johnson L; Schultze AE
    Vet Clin Pathol; 2017 Sep; 46(3):496-507. PubMed ID: 28841240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
    Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
    Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations.
    Duarte RCF; Ferreira CN; Rios DRA; Reis HJD; Carvalho MDG
    Rev Bras Hematol Hemoter; 2017; 39(3):259-265. PubMed ID: 28830606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation.
    Ramjee MK
    Anal Biochem; 2000 Jan; 277(1):11-8. PubMed ID: 10610684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of blood lipids on global coagulation test results.
    Kim JA; Kim JE; Song SH; Kim HK
    Ann Lab Med; 2015 Jan; 35(1):15-21. PubMed ID: 25553275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.